http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103788085-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103788085-B
titleOfInvention 2-(quinazoline-4-amino)-5-thiazole carboxamides analog derivative and bio-pharmaceutical purposes thereof
abstract The invention belongs to field of biological pharmacy, relate to 2 (quinazoline 4 amino) 5 thiazole carboxamides analog derivatives and bio-pharmaceutical purposes thereof, the present invention defines Src active pocket based on the complex crystal structure of high-quality Src receptor tyrosine kinase and its inhibitor saracatinib, and search known chemicals storehouse by virtual screening software DOCK at high speed and accurate scoring functions, it is thus achieved that Src is had 2 (quinazoline 4 amino) 5 thiazole carboxamides micromolecular compound of higher inhibitory activity.Through biological activity test, result confirms, described compound has relatively high inhibition effect to Src receptor tyrosine kinase, the tumour medicine that antineoplastic especially causes can be prepared because Src signal transduction of kinases system fading margin is disorderly, and as lead compound synthesizing new Src inhibitors of kinases, it is especially useful in treat the tumor disease relevant to Src.
priorityDate 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03078423-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005094376-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID48973
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492476
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID380430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17750911
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426157499
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409994468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10302451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5328940
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20779
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83805
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID458229
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396442
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41398
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID485864
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2M4I4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID325084
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35524
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419906721

Total number of triples: 42.